Core Scientific (CORZ) Gains from Investment Securities (2021 - 2026)
Core Scientific has reported Gains from Investment Securities over the past 6 years, most recently at $1.1 million for Q1 2026.
- Quarterly results put Gains from Investment Securities at $1.1 million for Q1 2026, up 18350.0% from a year ago — trailing twelve months through Mar 2026 was -$3.4 million (down 1281.56% YoY), and the annual figure for FY2024 was $3.4 million, down 7.24%.
- Gains from Investment Securities reached $1.1 million in Q1 2026 per CORZ's latest filing, up from -$300000.0 in the prior quarter.
- Across five years, Gains from Investment Securities topped out at $1.1 million in Q1 2026 and bottomed at -$31.6 million in Q4 2022.
- Median Gains from Investment Securities over the past 5 years was -$300000.0 (2025), compared with a mean of -$4.1 million.
- The largest annual shift saw Gains from Investment Securities crashed 1654.48% in 2025 before it skyrocketed 18350.0% in 2026.
- Over 5 years, Gains from Investment Securities stood at -$31.6 million in 2022, then soared by 100.78% to $247000.0 in 2023, then tumbled by 98.79% to $3000.0 in 2024, then plummeted by 10100.0% to -$300000.0 in 2025, then skyrocketed by 465.0% to $1.1 million in 2026.
- Business Quant data shows Gains from Investment Securities for CORZ at $1.1 million in Q1 2026, -$300000.0 in Q3 2025, and -$4.2 million in Q2 2025.